Viewing Study NCT06395103

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:12 PM
Ignite Modification Date: 2026-05-25 @ 12:43 PM
Study NCT ID: NCT06395103
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2024-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Sponsor: Merck Sharp & Dohme LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-cell Acute Lymphoblastic Leukemia View
None Diffuse Large B-cell Lymphoma View
None Burkitt Lymphoma View
None Neuroblastoma View
None Ewing Sarcoma View
Keywords: